Showing results (1171-1180 of 1,336) with videos related to

Sort By:
Pageof 134
Leukemia|July 14, 2019
Oxidative stress as candidate therapeutic target to overcome microenvironmental protection of CLLDeyan Yordanov Yosifov, Irina Idler, Nupur Bhattacharya, et al.
Acta Neuropathologica|October 24, 2015
Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Journal of Clinical Medicine|February 25, 2022
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional StudyDana Yelin, Ili Margalit, Mayssam Nehme, et al.
Molecular Genetics and Metabolism|June 5, 2012
Outcome of infants diagnosed with 3-methyl-crotonyl-CoA-carboxylase deficiency by newborn screeningGeorgianne L Arnold, Denise Salazar, Julie A Neidich, et al.
Nature Reviews. Nephrology|April 10, 2020
Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapyRupesh Raina, Jirair K Bedoyan, Uta Lichter-Konecki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2025
The climate and health impact of U.S. radiation therapy: estimating greenhouse gas emissions, DALYs, and potential of hypofractionationKatie E Lichter, Alyssa Asaro, Muhammad Mustafa Qureshi, et al.
Nature Communications|December 19, 2020
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtypeYonghe Wu, Michael Fletcher, Zuguang Gu, et al.
The Journal of Clinical Investigation|April 10, 2008
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomasStefan Pfister, Wibke G Janzarik, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastomaElke Pfaff, Marc Remke, Dominik Sturm, et al.
Molecular Genetics and Metabolism|July 22, 2019
Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patientsGeorge A Diaz, Andreas Schulze, Nicola Longo, et al.
Pageof 134